Blood-brain barrier permeability regulating agent and application thereof
The invention relates to application of SC79 or analogues thereof in preparation of a blood-brain barrier permeability regulating agent. The blood-brain barrier permeability regulating agent takes SC79 or an analogue thereof as an effective component; by activating Claudin-5 and Occludin signal path...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
04.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to application of SC79 or analogues thereof in preparation of a blood-brain barrier permeability regulating agent. The blood-brain barrier permeability regulating agent takes SC79 or an analogue thereof as an effective component; by activating Claudin-5 and Occludin signal paths at the downstream of the protein kinase B, the expression of the closely linked proteins Claudin-5and Occludin is reduced, and the expression of the Occludin is reduced. Therefore, the blood-brain barrier permeability is improved, the brain-entering transport efficiency of the brain-targeted drugdelivery system is enhanced, and especially, the brain-entering transport efficiency of the Angiopep-2 modified glycolipid nano-drug delivery system can be enhanced. The invention also relates to a kit, which comprises the blood-brain barrier permeability regulating agent and a brain-targeted drug delivery system. According to the invention, the blood-brain barrier permeability regulating agent and the brain-targeted drug |
---|---|
Bibliography: | Application Number: CN201910073172 |